Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 20.76% is in line with its 5-year average of 19.47%, around the middle of its 5-year range (15.25%–23.37%).
As of the fiscal period ended Tuesday, June 30, 2026. 1.01% below its 12-month average of 20.97%.
Reported quarterly operating margin; no daily interpolation.
OPERATING MARGIN
20.76%
OPERATING MARGIN AVG TTM
20.97%
OPERATING MARGIN AVG 3Y
20.72%
OPERATING MARGIN AVG 5Y
19.47%
OPERATING MARGIN AVG 10Y
17.34%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-1.01%
CURRENT VS 3Y AVG
+0.17%
CURRENT VS 5Y AVG
+6.60%
CURRENT VS 10Y AVG
+19.69%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
15.48%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+34.09%
vs the sector median at left
Medpace Holdings, Inc.
Market Cap
$16.11B
Operating Margin
20.76%
TTM Avg
20.97%
3Y Avg
20.72%
5Y Avg
19.47%
Market Cap
$16.97B
Operating Margin
17.49%
TTM Avg
19.66%
3Y Avg
22.41%
5Y Avg
27.16%
Market Cap
$14.80B
Operating Margin
25.54%
TTM Avg
19.38%
3Y Avg
20.05%
5Y Avg
20.47%
Market Cap
$14.10B
Operating Margin
11.77%
TTM Avg
17.41%
3Y Avg
16.25%
5Y Avg
15.86%
Market Cap
$18.17B
Operating Margin
15.61%
TTM Avg
16.64%
3Y Avg
15.15%
5Y Avg
12.43%
Market Cap
$13.51B
Operating Margin
-4.71%
TTM Avg
-1.31%
3Y Avg
-6.02%
5Y Avg
0.15%
Market Cap
$12.55B
Operating Margin
12.41%
TTM Avg
13.70%
3Y Avg
16.38%
5Y Avg
21.25%
Market Cap
$12.11B
Operating Margin
13.33%
TTM Avg
15.23%
3Y Avg
16.08%
5Y Avg
17.45%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | $16.11B | 20.76% | 20.97% | 20.72% | 19.47% |
| DaVita Inc. (DVA)vs › | $15.41B | 15.01% | 15.52% | 13.94% | 14.32% |
| Hologic, Inc. (HOLX)vs › | $16.97B | 17.49% | 19.66% | 22.41% | 27.16% |
| Solventum Corporation (SOLV)vs › | $14.80B | 25.54% | 19.38% | 20.05% | 20.47% |
| The Cooper Companies, Inc. (COO)vs › | $14.10B | 11.77% | 17.41% | 16.25% | 15.86% |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $18.17B | 15.61% | 16.64% | 15.15% | 12.43% |
| Baxter International Inc. (BAX)vs › | $13.51B | -4.71% | -1.31% | -6.02% | 0.15% |
| Revvity, Inc. (RVTY)vs › | $12.55B | 12.41% | 13.70% | 16.38% | 21.25% |
| Align Technology, Inc. (ALGN)vs › | $12.11B | 13.33% | 15.23% | 16.08% | 17.45% |
| Viatris Inc. (VTRS)vs › | $20.45B | -18.62% | -9.28% | -0.91% | -0.93% |
Gross Margin
28.8%
Operating Margin
20.8%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 20.76% |
| 2026-03-31 | 20.03% |
| 2025-12-31 | 21.63% |
| 2025-09-30 | 21.49% |
| 2025-06-30 | 20.94% |
| 2025-03-31 | 20.32% |
| 2024-12-31 | 23.37% |
| 2024-09-30 | 21.05% |
| 2024-06-30 | 19.91% |
| 2024-03-31 | 20.36% |
| 2023-12-31 | 17.52% |
| 2023-09-30 | 17.24% |
| 2023-06-30 | 17.01% |
| 2023-03-31 | 19.86% |
| 2022-12-31 | 19.39% |
| 2022-09-30 | 20.28% |
| 2022-06-30 | 17.15% |
| 2022-03-31 | 19.40% |
| 2021-12-31 | 17.78% |
| 2021-09-30 | 18.17% |
| 2021-06-30 | 15.25% |
| 2021-03-31 | 18.31% |
| 2020-12-31 | 21.18% |
| 2020-09-30 | 20.15% |
| 2020-06-30 | 14.70% |
| 2020-03-31 | 15.38% |
| 2019-12-31 | 15.71% |
| 2019-09-30 | 13.87% |
| 2019-06-30 | 16.47% |
| 2019-03-31 | 12.90% |
| 2018-12-31 | 15.96% |
| 2018-09-30 | 15.02% |
| 2018-06-30 | 13.72% |
| 2018-03-31 | 12.34% |
| 2017-12-31 | 13.70% |
| 2017-09-30 | 15.54% |
| 2017-06-30 | 15.33% |
| 2017-03-31 | 14.96% |
| 2016-12-31 | 11.91% |
| 2016-09-30 | 11.70% |
| 2016-06-30 | 13.32% |
| 2016-03-31 | 12.92% |
| 2015-12-31 | -0.93% |
| 2015-09-30 | 7.81% |
| 2015-06-30 | 8.95% |
| 2015-03-31 | 7.69% |
| 2014-03-31 | 2.36% |
